Clorox entered into a USD 1 billion 364-day revolving credit agreement with JPMorgan Chase, Citibank and Wells Fargo as administrative agents and lenders. The revolving facility is intended for general corporate purposes and matures on March 5, 2027, with an option to convert outstanding amounts into a term loan maturing on March 5, 2028. Clorox also entered into a USD 1.25 billion delayed-draw term credit agreement with the same bank group in connection with its planned acquisition of Gojo, the maker of PURELL.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Clorox Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001206774-26-000133), on March 10, 2026, and is solely responsible for the information contained therein.
Comments